The report covers forecast and analysis for the global non-opioid pain patches market. The study provides historic data from 2016 to 2018 along with forecast from 2019 to 2025 based on revenue (USD Million). In-depth secondary research is used to ascertain overall market size, top industry players, top product, industry associations, etc. Macro-economic indicators such as healthcare industry outlook, healthcare spending, research funding, GDP along with company websites, company annual reports, white papers, financial reports and other sources have also been considered to arrive at the indicated market numbers.
Non-opioid medications are antipyretic, analgesic, and anti-inflammatory in nature. These medications help decrease the development of pain in the peripheral nervous system by releasing the enzyme cyclooxygenase at the site of injury, which in turn blocks the production of prostaglandins. As per the stats provided by the United Nations Office on Drugs and Crime, almost 25 to 35 million people were abused by opioid globally. Due to rise in the rate of severe side-effects and addiction related to the prolonged use of opioid medication there has been an increased demand for the use of non-opioid therapeutics globally.
The study provides a decisive view on the non-opioid pain patches market by segmenting the market based on type, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on type the market is segmented into diclofenac patches, lidocaine patches, methyl salicylate patches, ketoprofen patches, capsaicin patches, and others. Lidocaine patches accounted for major share of the market in 2018 due to its proven efficacy and safety profile. These patches have are also recommended as first-line of therapy for treatment of neuropathic pain in elderly patients as well as those suffering from shingles.
Based on distribution channel the market is segmented into hospitals pharmacies, online pharmacies, drug stores, and others. Hospitals segment held major share of the market in 2018 due to frequent patient admissions and visits to the hospital for pain management, especially those suffering from musculoskeletal disorders and other diseases which cause chronic and acute pain. Besides, long-term use of painkillers brings risk of medication related adverse effects which are not the case in patches. Hence, physicians usually prescribe patches instead of oral drugs. Regional segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries.
The study also includes drivers and restraints for the non-opioid pain patches along with the impact they have on the demand over the forecast period. Besides, the report includes the study of opportunities and trends available in the non-opioid pain patches market on global level. Pain and disorders related to it are growing rapidly due to lifestyle changes, lack of physical activity, and rising number of surgical procedures. As per the U.S. Department of HHS (Health and Human Services) acute and chronic pain affects most of the Americans than cancer, diabetes, and heart related diseases combined. HHS has also reported that pain is one of the most common causes for visits of patients to healthcare facilities, which makes it the foremost cause of disability, thus contributing largely to the healthcare costs. These factors are leading to the discovery of effective and safe management options like non-opioid pain patches, which is boosting the market growth for these patches globally.
The report also provides company market share analysis in order to give a broader view of the key players in the market. Industry insights and information is delivered in the required format. ZMR develops a list of industry players (manufacturers), distributors, retailers and industry experts. Some of the players included in non-opioid pain patches market are Pfizer, Inc., Mylan N.V., GlaxoSmithKline Plc, Allergan, Hisamitsu Pharmaceutical Co. Inc., Teh Seng Pharmaceutical Mfg. Co., Acorda Therapeutics, Ltd., Teikoku Seiyaku Co. Ltd., and IBSA Institut Biochimque SA, Inc.
The report segments the non-opioid pain patches market as follows:
Global Non-Opioid Pain Patches Market: Type Segment Analysis
Global Non-Opioid Pain Patches Market: Distribution Channel Segment Analysis
Global Non-Opioid Pain Patches Market: Regional Segment Analysis
Non-opioid medications are antipyretic, analgesic, and anti-inflammatory in nature. These medications help decrease the development of pain in the peripheral nervous system by releasing the enzyme cyclooxygenase at the site of injury, which in turn blocks the production of prostaglandins. As per the stats provided by the United Nations Office on Drugs and Crime, almost 25 to 35 million people were abused by opioid globally. Due to rise in the rate of severe side-effects and addiction related to the prolonged use of opioid medication there has been an increased demand for the use of non-opioid therapeutics globally.
The study provides a decisive view on the non-opioid pain patches market by segmenting the market based on type, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on type the market is segmented into diclofenac patches, lidocaine patches, methyl salicylate patches, ketoprofen patches, capsaicin patches, and others. Lidocaine patches accounted for major share of the market in 2018 due to its proven efficacy and safety profile. These patches have are also recommended as first-line of therapy for treatment of neuropathic pain in elderly patients as well as those suffering from shingles.
Based on distribution channel the market is segmented into hospitals pharmacies, online pharmacies, drug stores, and others. Hospitals segment held major share of the market in 2018 due to frequent patient admissions and visits to the hospital for pain management, especially those suffering from musculoskeletal disorders and other diseases which cause chronic and acute pain. Besides, long-term use of painkillers brings risk of medication related adverse effects which are not the case in patches. Hence, physicians usually prescribe patches instead of oral drugs. Regional segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries.
The study also includes drivers and restraints for the non-opioid pain patches along with the impact they have on the demand over the forecast period. Besides, the report includes the study of opportunities and trends available in the non-opioid pain patches market on global level. Pain and disorders related to it are growing rapidly due to lifestyle changes, lack of physical activity, and rising number of surgical procedures. As per the U.S. Department of HHS (Health and Human Services) acute and chronic pain affects most of the Americans than cancer, diabetes, and heart related diseases combined. HHS has also reported that pain is one of the most common causes for visits of patients to healthcare facilities, which makes it the foremost cause of disability, thus contributing largely to the healthcare costs. These factors are leading to the discovery of effective and safe management options like non-opioid pain patches, which is boosting the market growth for these patches globally.
The report also provides company market share analysis in order to give a broader view of the key players in the market. Industry insights and information is delivered in the required format. ZMR develops a list of industry players (manufacturers), distributors, retailers and industry experts. Some of the players included in non-opioid pain patches market are Pfizer, Inc., Mylan N.V., GlaxoSmithKline Plc, Allergan, Hisamitsu Pharmaceutical Co. Inc., Teh Seng Pharmaceutical Mfg. Co., Acorda Therapeutics, Ltd., Teikoku Seiyaku Co. Ltd., and IBSA Institut Biochimque SA, Inc.
The report segments the non-opioid pain patches market as follows:
Global Non-Opioid Pain Patches Market: Type Segment Analysis
- Lidocaine Patches
- Diclofenac Patches
- Methyl Salicylate Patches
- Capsaicin Patches
- Ketoprofen Patches
- Others
Global Non-Opioid Pain Patches Market: Distribution Channel Segment Analysis
- Hospitals Pharmacies
- Online Pharmacies
- Drug Stores
- Others
Global Non-Opioid Pain Patches Market: Regional Segment Analysis
- North America
- U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
Table of Contents
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Non-Opioid Pain Patches Market, 2016 - 2025, (USD Million)
- 2.2. Non-Opioid Pain Patches Market: Market Snapshot
- Chapter 3. Global Non-Opioid Pain Patches Market - Industry Analysis
- 3.1. Non-Opioid Pain Patches Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Increasing use of opioid prescriptions
- 3.2.2. Increasing incidence of pain related disorders
- 3.2.3. Benefits offered by non-opioid pain patches over other forms of medication
- 3.3. Restraints
- 3.3.1. Side effects caused by prolonged use of non-opioid pain patches
- 3.4. Opportunity
- 3.4.1. Development of patches without side effects
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by type segment
- 3.6.2. Market attractiveness analysis by distribution channel segment
- 3.6.3. Market attractiveness analysis by regional segment
- Chapter 4. Global Non-Opioid Pain Patches Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global non-opioid pain patches market: company market share analysis, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New type launches
- 4.2.3. Agreements, partnerships, collaborations and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Non-Opioid Pain Patches Market -Type Segment Analysis
- 5.1. Global non-opioid pain patches market overview: by type
- 5.1.1. Global non-opioid pain patches market revenue share, by type, 2018 and 2025
- 5.2. Lidocaine Patches
- 5.2.1. Global non-opioid pain patches market by lidocaine patches, 2016 - 2025 (USD Million)
- 5.3. Diclofenac Patches
- 5.3.1. Global non-opioid pain patches market by diclofenac patches, 2016 - 2025 (USD Million)
- 5.4. Methyl Salicylate Patches
- 5.4.1. Global non-opioid pain patches market by methyl salicylate patches, 2016 - 2025 (USD Million)
- 5.5. Capsaicin Patches
- 5.5.1. Global non-opioid pain patches market by capsaicin patches, 2016 - 2025 (USD Million)
- 5.6. Ketoprofen Patches
- 5.6.1. Global non-opioid pain patches market by ketoprofen patches, 2016 - 2025 (USD Million)
- 5.7. Others
- 5.7.1. Global non-opioid pain patches market by others, 2016 - 2025 (USD Million)
- 5.1. Global non-opioid pain patches market overview: by type
- Chapter 6. Global Non-Opioid Pain Patches Market - Distribution Channel Segment Analysis
- 6.1. Global non-opioid pain patches market overview: by distribution channel
- 6.1.1. Global non-opioid pain patches market revenue share, by distribution channel, 2018 and 2025
- 6.2. Hospital Pharmacies
- 6.2.1. Global non-opioid pain patches market by hospital pharmacies, 2016 - 2025 (USD Million)
- 6.3. Online Pharmacies
- 6.3.1. Global non-opioid pain patches market by online pharmacies, 2016 - 2025 (USD Million)
- 6.4. Drug Stores
- 6.4.1. Global non-opioid pain patches market by drug stores, 2016 - 2025 (USD Million)
- 6.5. Others
- 6.5.1. Global non-opioid pain patches market by others, 2016 - 2025 (USD Million)
- 6.1. Global non-opioid pain patches market overview: by distribution channel
- Chapter 7. Global Non-Opioid Pain Patches Market - Regional Analysis
- 7.1. Global non-opioid pain patches market overview: by region
- 7.1.1. Global non-opioid pain patches market revenue share, by region, 2018 and 2025
- 7.2. North America
- 7.2.1. North America non-opioid pain patches market, by country, 2016 - 2025 (USD Million)
- 7.2.2. North America non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.2.3. North America non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.2.4. The U.S.
- 7.2.4.1. The U.S. non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.2.4.2. The U.S. non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.2.5. Rest of North America
- 7.2.5.1. Rest of North America non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.2.5.2. Rest of North America non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.3. Europe
- 7.3.1. Europe non-opioid pain patches market, by country, 2016 - 2025 (USD Million)
- 7.3.2. Europe non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.3.3. Europe non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.3.4. U.K.
- 7.3.4.1. U.K. non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.3.4.2. U.K. non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.3.5. Germany
- 7.3.5.1. Germany non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.3.5.2. Germany non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.3.6. France
- 7.3.6.1. France non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.3.6.2. France non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.3.7. Rest of Europe
- 7.3.7.1. Rest of Europe non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.3.7.2. Rest of Europe non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific non-opioid pain patches market, by country, 2016 - 2025 (USD Million)
- 7.4.2. Asia Pacific non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.4.3. China
- 7.4.3.1. China non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.4.3.2. China non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.4.4. Japan
- 7.4.4.1. Japan non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.4.4.2. Japan non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.4.5. India
- 7.4.5.1. India non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.4.5.2. India non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.4.6. Rest of Asia Pacific
- 7.4.6.1. Rest of Asia Pacific non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.4.6.2. Rest of Asia Pacific non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America non-opioid pain patches market, by country, 2016 - 2025 (USD Million)
- 7.5.2. Latin America non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.5.3. Brazil
- 7.5.3.1. Brazil non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.5.3.2. Brazil non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.5.4. Rest of Latin America
- 7.5.4.1. Rest of Latin America non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.5.4.2. Rest of Latin America non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.6. Middle East & Africa
- 7.6.1. Middle East & Africa non-opioid pain patches market, 2016 - 2025 (USD Million)
- 7.6.2. Middle East & Africa non-opioid pain patches market revenue, by type, 2016 - 2025 (USD Million)
- 7.6.3. Middle East & Africa non-opioid pain patches market revenue, by distribution channel, 2016 - 2025 (USD Million)
- 7.1. Global non-opioid pain patches market overview: by region
- Chapter 8. Company Profiles
- 8.1. Pfizer, Inc.
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Mylan N.V.
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. GlaxoSmithKline Plc
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Developments
- 8.4. Allergan
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Developments
- 8.5. Hisamitsu Pharmaceutical Co., Inc.
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Developments
- 8.6. Teh Seng Pharmaceutical Mfg., Co.
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategy
- 8.6.5. Recent Developments
- 8.7. Acorda Therapeutics, Ltd.
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategy
- 8.7.5. Recent Developments
- 8.8. Teikoku Seiyaku Co., Ltd.
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategy
- 8.8.5. Recent Developments
- 8.9. IBSA Institut Biochimque SA, Inc.
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategy
- 8.9.5. Recent Developments
- 8.1. Pfizer, Inc.
